Premium
Evaluation of Potential Therapeutic Options for COVID‐19
Author(s) -
Austin Daren,
Okour Malek
Publication year - 2020
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/jcph.1669
Subject(s) - nitazoxanide , hydroxychloroquine , pharmacology , niclosamide , population , chloroquine , in vivo , medicine , pharmacokinetics , drug , ic50 , darunavir , in vitro , virology , chemistry , virus , biology , immunology , viral load , covid-19 , disease , malaria , biochemistry , antiretroviral therapy , ecology , environmental health , microbiology and biotechnology , infectious disease (medical specialty)